Cargando…

Macular pigment response to a supplement containing meso-zeaxanthin, lutein and zeaxanthin

BACKGROUND: Age-related macular degeneration (AMD) is a disease with multiple risk factors, many of which appear to involve oxidative stress. Macular pigment, with its antioxidant and light-screening properties, is thought to be protective against AMD. A result has been the appearance of dietary sup...

Descripción completa

Detalles Bibliográficos
Autores principales: Bone, Richard A, Landrum, John T, Cao, Yisi, Howard, Alan N, Alvarez-Calderon, Francesca
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1872023/
https://www.ncbi.nlm.nih.gov/pubmed/17498306
http://dx.doi.org/10.1186/1743-7075-4-12
_version_ 1782133459060260864
author Bone, Richard A
Landrum, John T
Cao, Yisi
Howard, Alan N
Alvarez-Calderon, Francesca
author_facet Bone, Richard A
Landrum, John T
Cao, Yisi
Howard, Alan N
Alvarez-Calderon, Francesca
author_sort Bone, Richard A
collection PubMed
description BACKGROUND: Age-related macular degeneration (AMD) is a disease with multiple risk factors, many of which appear to involve oxidative stress. Macular pigment, with its antioxidant and light-screening properties, is thought to be protective against AMD. A result has been the appearance of dietary supplements containing the macular carotenoids, lutein and zeaxanthin. More recently, a supplement has been marketed containing, in addition, the third major carotenoid of the macular pigment, meso-zeaxanthin. The purpose of the study was to determine the effectiveness of such a supplement in raising macular pigment density in human subjects. METHODS: A 120 day supplementation study was conducted in which 10 subjects were given gel-caps that provided 20 mg/day of predominantly meso-zeaxanthin, with smaller amounts of lutein and zeaxanthin. A second group of 9 subjects were given gel caps containing a placebo for the same 120 day period. Prior to and during the supplementation period, blood serum samples were analyzed by high performance liquid chromatography for carotenoid content. Similarly, macular pigment optical density was measured by heterochromatic flicker photometry. Differences in response between the supplementation and placebo groups were tested for significance using a student's t-test. RESULTS: During supplementation with the carotenoids, blood samples revealed the presence of all three carotenoids. Macular pigment optical density, measured at 460 nm, rose at an average rate of 0.59 ± 0.79 milli-absorbance unit/day in the 10 supplemented subjects. This was significantly different from the placebo group (9 subjects) for whom the average rate was -0.17 ± 0.42 milli-absorbance units/day. CONCLUSION: We have shown for the first time that meso-zeaxanthin is absorbed into the serum following ingestion. The data indicate that a supplement containing predominantly meso-zeaxanthin is generally effective at raising macular pigment density, and may turn out to be a useful addition to the defenses against AMD.
format Text
id pubmed-1872023
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-18720232007-05-18 Macular pigment response to a supplement containing meso-zeaxanthin, lutein and zeaxanthin Bone, Richard A Landrum, John T Cao, Yisi Howard, Alan N Alvarez-Calderon, Francesca Nutr Metab (Lond) Research BACKGROUND: Age-related macular degeneration (AMD) is a disease with multiple risk factors, many of which appear to involve oxidative stress. Macular pigment, with its antioxidant and light-screening properties, is thought to be protective against AMD. A result has been the appearance of dietary supplements containing the macular carotenoids, lutein and zeaxanthin. More recently, a supplement has been marketed containing, in addition, the third major carotenoid of the macular pigment, meso-zeaxanthin. The purpose of the study was to determine the effectiveness of such a supplement in raising macular pigment density in human subjects. METHODS: A 120 day supplementation study was conducted in which 10 subjects were given gel-caps that provided 20 mg/day of predominantly meso-zeaxanthin, with smaller amounts of lutein and zeaxanthin. A second group of 9 subjects were given gel caps containing a placebo for the same 120 day period. Prior to and during the supplementation period, blood serum samples were analyzed by high performance liquid chromatography for carotenoid content. Similarly, macular pigment optical density was measured by heterochromatic flicker photometry. Differences in response between the supplementation and placebo groups were tested for significance using a student's t-test. RESULTS: During supplementation with the carotenoids, blood samples revealed the presence of all three carotenoids. Macular pigment optical density, measured at 460 nm, rose at an average rate of 0.59 ± 0.79 milli-absorbance unit/day in the 10 supplemented subjects. This was significantly different from the placebo group (9 subjects) for whom the average rate was -0.17 ± 0.42 milli-absorbance units/day. CONCLUSION: We have shown for the first time that meso-zeaxanthin is absorbed into the serum following ingestion. The data indicate that a supplement containing predominantly meso-zeaxanthin is generally effective at raising macular pigment density, and may turn out to be a useful addition to the defenses against AMD. BioMed Central 2007-05-11 /pmc/articles/PMC1872023/ /pubmed/17498306 http://dx.doi.org/10.1186/1743-7075-4-12 Text en Copyright © 2007 Bone et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Bone, Richard A
Landrum, John T
Cao, Yisi
Howard, Alan N
Alvarez-Calderon, Francesca
Macular pigment response to a supplement containing meso-zeaxanthin, lutein and zeaxanthin
title Macular pigment response to a supplement containing meso-zeaxanthin, lutein and zeaxanthin
title_full Macular pigment response to a supplement containing meso-zeaxanthin, lutein and zeaxanthin
title_fullStr Macular pigment response to a supplement containing meso-zeaxanthin, lutein and zeaxanthin
title_full_unstemmed Macular pigment response to a supplement containing meso-zeaxanthin, lutein and zeaxanthin
title_short Macular pigment response to a supplement containing meso-zeaxanthin, lutein and zeaxanthin
title_sort macular pigment response to a supplement containing meso-zeaxanthin, lutein and zeaxanthin
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1872023/
https://www.ncbi.nlm.nih.gov/pubmed/17498306
http://dx.doi.org/10.1186/1743-7075-4-12
work_keys_str_mv AT bonericharda macularpigmentresponsetoasupplementcontainingmesozeaxanthinluteinandzeaxanthin
AT landrumjohnt macularpigmentresponsetoasupplementcontainingmesozeaxanthinluteinandzeaxanthin
AT caoyisi macularpigmentresponsetoasupplementcontainingmesozeaxanthinluteinandzeaxanthin
AT howardalann macularpigmentresponsetoasupplementcontainingmesozeaxanthinluteinandzeaxanthin
AT alvarezcalderonfrancesca macularpigmentresponsetoasupplementcontainingmesozeaxanthinluteinandzeaxanthin